Abbott Web-Based Lab Information Management System

Oct 22, 2018

Abbott announced the launch of a web-based laboratory information management system to enable labs to make data management simpler, better integrated, and more user-friendly. StarLIMS Life Sciences Solution CL 11.0 includes pre-clinical research, clinical research, and biorepository, molecular, and academic research, Abbott said.

The firm said that continual improvements in laboratory information management system platforms are crucial as regulatory scrutiny increases, the amount of data grows exponentially, some industries move toward molecular testing and precision medicine, and pressure mounts to bring new products to market faster.

The products' advanced analytics allows clients to analyze lab data via enhanced data visualization capabilities, which enables better, faster, and business-critical decision making, Abbott said.

More Like This

Jan 09, 2019

Sclero-Smart

Specialty biotech firm Gemelli Biotech has launched Sclero-Smart, a blood-based test that measures levels of anti-vinculin, an autoantibody which has been found to be elevated in sclerodema patients and associated with gastrointestinal complications. The finding of the association suggests a link between sclerodema and the gut microbiome, the Los Angeles-based firm said, and could lead to new microbiome-related diagnostic tools and therapeutics for the disease. The Sclero-Smart, which uses an ELISA format measures anti-vinculin levels in patients with systemic sclerosis and sclerodema. 

Jan 08, 2019

Yourgene Sage 32 Plex

Yourgene Health has launched the Sage 32 plex test, a high-throughput noninvasive prenatal testing and analysis solution for clinical laboratories. It runs on Thermo Fisher Scientific's Ion Torrent sequencing platform and allows 32 samples to be processed in parallel. The test, which will be available internationally, has improved performance due to workflow enhancements and upgraded analysis methods. Yourgene plans to launch a CE-IVD-marked version of the library preparation kit for the Sage 32 plex workflow in the coming months. The Sage test differs from Yourgene's other NIPT, the Iona test, in that it screens for a wider range of conditions, including trisomies 21, 18, and 13; sex chromosome aneuploidies; and clinically relevant microdeletions. The analysis uses a cloud-based bioinformatics solution called Sage Link.

Dec 21, 2018

Contextual Genomics 'Find It' and 'Follow It' Assays

Contextual Genomics, a Vancouver, Canada-based cancer genomics company, said that it has completed development of two new products: an improved version of its Find It hotspot panel for detection of genomic mutations in solid tumour cancers; and its Follow It hotspot panel for detection of the same genomic mutations in blood plasma.

The Find It panel now screens for 146 somatic genome alterations found in solid tumor cancers to identify optimal therapeutic treatments and recognize acquired drug resistance mutations. The assay is supported by Contextual's cloud-based genome analysis engine (CGIRP).

The Follow It panel screens for cell-free circulating tumour DNA in plasma, and is designed to  be used in patients with widespread metastatic disease at diagnosis and as a time series monitoring tool to read out tumor burden and treatment resistance. Follow It will screen for all of the same somatic genome alterations as Find It and can be used to follow disease progression for patients, including those whose tumors were initially tested with Find It.

Dec 21, 2018

DiaSorin Molecular Primer Pairs

DiaSorin Molecular has introduced three new primer pairs for Legionella species, Chlamydophila pneumoniae, and Mycoplasma pneumoniae, which can be used in laboratory-developed tests. The firm noted that it now offers more than 55 analyte-specific reagents.

Dec 20, 2018

Viracor Eurofins 16S NGS Bacterial Meningitis Test

Viracor Eurofins recently launched its 16S Next-Generation Sequencing Bacterial Meningitis test. The assay amplifies the 16S gene utilizing PCR, followed by NGS to identify and report the bacterial pathogen in a patient's CSF sample. The assay was validated to include the most common bacterial pathogens associated with meningitis: Streptococcus pneumoniae, Neisseria meningitidisHaemophilus influenzaeListeria monocytogenesStreptococcus agalactiae (Group B Strep), and Escherichia coli, as well as other less common pathogens that may be clinically important in immunocompromised patient populations (HIV-positive, solid organ transplant, or hematopoietic cell transplant patients). Physicians will receive test results for difficult-to-diagnose immunocompromised patients within three business days from specimen receipt, the company said.

Dec 14, 2018

Microbiologics Group A Streptococcus and Respiratory Control Panels

Microbiologics has launched its Group A Streptococcus and Respiratory Panels, as well as test meothods to help clinical laboratories deliver accurate results during cold and flu season. The panels include features such as multiplexed pellets, swabs that mimic patient sample processing, and room temperature storage. 

Dec 11, 2018

ZeptoMetrix Pneumonia Verification Panels

ZeptoMetrix has released two pneumonia verification panels for molecular quality control, the NATrol Pneumonia Panel-Atypical Bacteria & Viruses and NATrol Pneumonia Panel-Quantifiable Bacteria. The Buffalo, New York-based company designs, develops, and markets solutions for the infectious disease diagnostics space. 

Dec 10, 2018

SQI Imaware Celiac Disease Test

SQI Diagnostics has launched the Imaware home-based test for celicac disease developed by Microdrop. The test is run on SQI's automated system. Other Imaware tests running on the SQI platform are expected to launch in 2019, including a home-based test for rheumatoid arthritis, SQI said.

Dec 03, 2018

Insight Genetics Insight TNBCtype

Insight Genetics has launched Insight TNBCtype, a new test for categorizing triple negative breast cancers (TNBC) into distinct molecular subtypes. Offered through its CLIA-certified and CAP-accredited lab, Insight Molecular Labs, the new test is intended to help advance prospective clinical trials of targeted therapies for TNBC patients.

TNBC, which represents up to 15-20 percent of all breast cancers, is an aggressive disease, characterized by an absence of ER, PR, and HER2 expression. Insight TNBCtype is based on a proprietary algorithm that uses gene expression data from next-generation sequencing to generate five molecular subtypes (BL1, BL2, LAR, MSL and M), as well as a complementary immunomodulatory (IM) classifier that may help predict response to immuno-oncology therapies. 

Nov 30, 2018

Qiagen QiaScreen HPV PCR Test

Qiagen announced the European launch of its QiaScreen HPV PCR test, a CE-IVD marked molecular diagnostic assay for 15 recognized high-risk genotypes of human papillomavirus associated with cervical cancer. The assay is designed to detect a range of DNA targets within the E7 region of the HPV virus, providing the flexibility of PCR without the risk of false positives due to L1 deletion, Qiagen said. The clinical performance of the assay was tested using nearly 1,600 samples from the Valgent-3 panel, and was reported to have a clinical sensitivity and specificity to CIN3+ of 97.3 percent and 89.0 percent, respectively. The assay is designed for use on either clinician-collected or self-collected specimens, and it has been validated on Qiagen's Rotor-Gene Q MDx system. Qiagen also intends to offer a version of the test on the NeuMoDx 96 and 288 molecular systems in the future for customers desiring higher-volume testing and full integration.

Nov 27, 2018

Roche Ventana pan-TRK Assay

Roche has launched its new Ventana pan-TRK Assay, which detects tropomyosin receptor kinase proteins in cancer. According to the firm, laboratories can now identify wild-type and chimeric fusion proteins by detecting the TRK C-terminal region. Researchers can run the assay on Roche's benchmark series of IHC/ISH automated staining instruments. 

Nov 27, 2018

Roche Diagnostics LabOPS and Dx Optimization

Roche Diagnostics has launched two new apps aimed at helping hospital labs improve efficiency and effectiveness. LabOPS helps labs and hospitals access their own data more effectively and make fact-based decisions around the operational and financial processes of their institutions. It is intended to reduce waste. LabOPS is available in five languages: English, French, German, Spanish and Portuguese. Dx Optimization offers data-based insight to optimize physician ordering protocols and improve decisions made around clinical effectiveness. The app can identify over and under ordering of a test, which can increase costs and decrease quality of care. It is available in English for the US and Canada.

Nov 09, 2018

Proteomics International PromarkerD

Proteomics International has launched the new PromarkerD immunoassay kit following the completion of production of key antibody reagents. The new kit will be used to target new commercialization deals in Japan and India. PromarkerD is for predicting the onset of diabetic kidney disease and can be used by pathology labs. 

Nov 08, 2018

Hologic Panther Fusion Open Access Functionality

Hologic has introduced an Open Access functionality that will allow CLIA-certified laboratories to develop laboratory developed tests to run on its fully automated Panther Fusion platform. Labs will be able to run their LDTs simultaneously with commercially available IVD assays, and results will release automatically to laboratory information systems.

The Open Access functionality is enabled by the new myAccess software, which is designed to help laboratories create protocols, analyze data, set thresholds, and interpret results, Hologic said.

Nov 07, 2018

QuestDirect

Quest Diagnostics announced the launch of QuestDirect, a consumer-initiated testing service that empowers patients to order health and wellness lab testing from home. The service, available in 48 states, offers 35 test packages for general health, men's and women's health, digestive health, heart health, infectious disease, and sexually transmitted disease testing. Consumers can order by visiting the QuestDirect website and choosing their own lab tests. Independent physicians will provide oversight and, if appropriate, order the testing. Consumers can make appointments online to visit a Quest patient service center. Results are typically available within a week, and can be accessed through MyQuest, where they can be shared with the consumer's doctor or family members through a new "My Circle" feature.

Feb
14
Sponsored by
Oxford Nanopore Technologies

This webinar will describe a project that applied Oxford Nanopore long-read RNA-seq to explore the transcriptional landscape of a damaging agricultural pest.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

Feb
26
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease.